Wikipedia
Otenabant
Otenabant (CP-945,598) is a drug which acts as a potent and highly selective CB antagonist. It was developed by Pfizer for the treatment of obesity, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.